IndraLab

Statements



reach
"Further study revealed that WEL treatment dramatically inhibited NLRP3 inflammasome activation and caspase-1 phosphorylation to decrease IL-1beta release in colons treated with DSS."

reach
"DCA Administration Exacerbates DSS Induced Colitis and Caspase-1 Inhibition Exhibits Significant Protective Role."